Search - tctmd.com

Displaying 61 - 80 of 132

Sort: Relevancy | Date

News Daily News

July 2020 News Roundup

L.A. McKeown

July 01, 2020

News Conference News TVT 2020

Device Explants After TAVR Rare but Risky

Michael O'Riordan

June 24, 2020

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

News Daily News

SAVR After Failed TAVR: Rare and Risky, Registry Study Finds

Yael L. Maxwell

June 10, 2020

News Conference News ACC 2020

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Yael L. Maxwell

March 29, 2020

News Daily News

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Michael O'Riordan

March 11, 2020

News Daily News

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Yael L. Maxwell

February 28, 2020

News Conference News CRT 2020

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

Michael O'Riordan

February 27, 2020

News Conference News CRT 2020

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

Michael O'Riordan

February 26, 2020

News Industry News

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

February 25, 2020

News Daily News

ViV TAVR Bests Redo Surgery for Failed Valves: Retrospective Study

Yael L. Maxwell

January 16, 2020

News Conference News PCR London Valves 2019

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

Michael O'Riordan

November 20, 2019

News Conference News PCR London Valves 2019

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Michael O'Riordan

November 20, 2019

News Daily News

Cardiac Rehab Tied to Fewer Hospitalizations, Deaths After Valve Surgery

Todd Neale

October 23, 2019

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

Presentation TCT 2019

A Modern Approach to Bioprosthetic Valve Deterioration and Failure: Emerging Data After TAVR

Presenter: Davide Capodanno

September 26, 2019

News Industry News

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

September 12, 2019

News Daily News

Oral Anticoagulation Post-AVR Safe but Not Routinely Needed: PARTNER II

Caitlin E. Cox

August 27, 2019

News Conference News TVT 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Michael O'Riordan

June 20, 2019

Presentation TVT 2019

Case Intervention and Outcomes

Presenter: Hasan Jilaihawi

June 12, 2019

Advertisement

July 2020 News Roundup

Device Explants After TAVR Rare but Risky

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

SAVR After Failed TAVR: Rare and Risky, Registry Study Finds

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

ViV TAVR Bests Redo Surgery for Failed Valves: Retrospective Study

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Cardiac Rehab Tied to Fewer Hospitalizations, Deaths After Valve Surgery

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

A Modern Approach to Bioprosthetic Valve Deterioration and Failure: Emerging Data After TAVR

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

Oral Anticoagulation Post-AVR Safe but Not Routinely Needed: PARTNER II

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Case Intervention and Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content